We are live on ! Find out more
CORV

Correvio Pharma Corp. Ordinary Shares (Canada)
CORV

Delisted

CORV was delisted on the 26th of May, 2020.

17 hedge funds and large institutions have $3.54M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2013 Q2 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

6,200% more call options, than puts

Call options by funds: $63K | Put options by funds: $1K

Holders
17
Holders Change
+17
Holders Change %
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
Reduced
Closed
Calls
$63K
Puts
$1K
Net Calls
+$62K
Net Calls Change
+$62K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

CORV Hedge Fund Activity: Q2 2013 in Review

17 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q2 2013, worth a combined $3.54M.

Buyers outnumbered sellers: 17 funds opened new CORV positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.

  • 17 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $3.54M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q2 2013.
  • 17 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q2 2013 and 0 closed out, a net change of +17 holders.

Based on aggregated 13F filings for Q2 2013.